Eli Lilly and Co

Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly‘s stock is still recovering after the drugmaker released trial data earlier this month on its closely watched obesity pill that underwhelmed Wall Street. In a key late-stage trial, […]
Read More
CNBC’s UK Exchange newsletter: The price is REIT
This report is from this week’s CNBC’s UK Exchange newsletter. Each Wednesday, Ian King brings you expert insights on the most important business stories from the U.K. and other key developments you won’t want to miss. Like what you see? You can subscribe here. The dispatch Episodes in which the mighty KKR receives a bloody nose […]
Read More
FDA approves first-ever glucose monitoring system for weight loss from Signos
Woman with Signos wearable and app Source: Signos The Food and Drug Administration on Wednesday approved the first-ever glucose monitoring system specifically for weight loss from the startup Signos, establishing a new option for Americans to manage their weight. Current treatment options for losing weight – popular drugs like GLP-1s and surgical interventions – are […]
Read More
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
Shares of Viking Therapeutics fell more than 30% in premarket trading Tuesday after the company released mid-stage trial data on its obesity pill that disappointed investors. The results could be a blow to Viking, which was once seen as a hot M&A target as pharmaceutical companies scramble to join the booming market for obesity and […]
Read More
Eli Lilly’s 170% UK price hike for Mounjaro is just the start as pharma firms bow to Trump’s pricing pressures
Key Points Pharma giants are navigating U.S. President Donald Trump’s demands to bring U.S. drug prices in line with other developed nations. Eli Lilly’s decision to hike Mounjaro prices in the U.K. could spark similar moves from other firms, analysts say. The U.S. consistently pays the most in the world for many prescription drugs. Eli Lilly ‘s […]
Read More
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
A box of Ozempic made by Novo Nordisk, at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it now offers cash-paying U.S. patients its blockbuster diabetes treatment Ozempic for less than half its monthly list price, as drugmakers face mounting political pressure to lower prices in […]
Read More
Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs
Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 9, 2024. Nurphoto | Nurphoto | Getty Images Eli Lilly on Thursday said it is raising the list price of its blockbuster diabetes drug Mounjaro in the U.K. starting in September, as […]
Read More
Stocks making the biggest moves midday: Firefly Aerospace, Fortinet, Duolingo, Eli Lilly and more
Check out some of the companies making headlines in midday trading: Firefly Aerospace — Shares of the Texas-based rocket maker surged more than 50% as they debuted Thursday afternoon on the Nasdaq under the “FLY” ticker symbol. On Wednesday, the stock priced in its initial public offering at $45 each, which was above its expected […]
Read More
Stocks making the biggest moves premarket: Eli Lilly, Peloton, Intel, Duolingo and more
Check out the companies making headlines before the bell. Eli Lilly — The pharmaceutical stock dropped more than 7% despite posting a second-quarter earnings and revenue beat . The company also raised guidance for both its full-year earnings and revenue. Meantime, Eli Lilly reported that the highest dose of an experimental daily pill helped patients […]
Read More